Innovations

• since 2011 we have the ability to produce "Low Alkali" ampoules (form B/C) with a sodium release less than 50% from the approved threshold
• furthermore we offer the possibility to neutralize the inner surface of our vials
• since 12.12.2011 registration Drug Master File (DMF) Type III
• till the end of 2012 our existing DIN EN ISO certification will be extended to DIN EN ISO 15378